FindTrial
Sign In

A randomized controlled trial for remifentanil in the pre-emptive treatment of pain associated with sputum suction in patients under mechanical ventilation: research protocol of sedation and analgesia

A randomized controlled trial for remifentanil in the pre-emptive treatment of pain associated with sputum suction in patients under mechanical ventilation: research protocol of sedation and analgesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021380
Enrollment
Unknown
Registered
2019-02-17
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

all patients in EICU

Interventions

lower dose group:remifentanil
higher dose group:remifentanil

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 14 to 85 years; 2. Need for mechanical ventilation for at least 24 hours; 3. Hemodynamic stability; 4. Understanding the language of the country; 5. A legal representative who consents to the patients participation.

Exclusion criteria

Exclusion criteria: 1. Known hypersensitivity to remifentanil; 2. Treatment with neuromuscular blocking agents; 3. Cognitive disorders; 4. Brain death or vegetative state; 5. Pregnancy.

Design outcomes

Primary

MeasureTime frame
the adverse events which were obviously correlated with Sedation and analgesia;—

Secondary

MeasureTime frame
CPOT score before and after sputum suction;RASS score before and after sputum suction;—

Countries

China

Contacts

Public ContactPeng Deng

Emergency Department, West China Hospital, Sichuan University

326038901@qq.com+86 13689042273

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026